Please enable JavaScript to continue using this application.

Compare $SNDX vs $STOK | Chartloom

Compare

$SNDX vs $STOK

Syndax Pharmaceuticals Inc · Stoke Therapeutics Inc

SNDX

Syndax Pharmaceuticals Inc

STOK

Stoke Therapeutics Inc

Compare $SNDX vs $STOK

Comparing Syndax Pharmaceuticals Inc and Stoke Therapeutics Inc

SNDXSyndax Pharmaceuticals Inc

STOKStoke Therapeutics Inc

SNDXSyndax Pharmaceuticals Inc

Market cap

$1.51B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

222.7%

YTD performance

-20.2%

52W performance

3.0%

FCF yield

-14.7%

STOKStoke Therapeutics Inc

Market cap

$1.54B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

47.27x

Rev growth (TTM)

-86.2%

YTD performance

-19.9%

52W performance

-18.9%

FCF yield

-11.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

SNDX

STOK

Detailed metrics comparison

SNDX

Syndax Pharmaceuticals Inc

STOK

Stoke Therapeutics Inc

Market Cap

SNDX$1.51B

STOK$1.54B

Enterprise Value

SNDX$1.76B

STOK$1.43B

Price

SNDX$16.99

STOK$24.74

P/E Ratio

SNDXN/A

STOKN/A

P/S Ratio

SNDX5.97x

STOK55.85x

EV/Sales

SNDX6.97x

STOK51.86x

EV/EBITDA

SNDX1,613.51x

STOK53.69x

P/B Ratio

SNDX104.09x

STOK4.78x

P/FCF Ratio

SNDXN/A

STOKN/A

EV/FCF

SNDX-7.96x

STOK-7.92x

PEG Ratio

SNDXN/A

STOKN/A

Forward P/E (NTM)

SNDXN/A

STOKN/A

Forward P/S (NTM)

SNDXN/A

STOK47.27x

Revenue (TTM)

SNDX$252M

STOK$28M

Revenue Growth (YoY)

SNDX222.7%

STOK-86.2%

Forward Rev Growth

SNDX41.0%

STOK62.9%

Gross Margin (TTM)

SNDX95.8%

STOK0.0%

Operating Margin (TTM)

SNDX0.0%

STOK0.0%

EBITDA Margin (TTM)

SNDX-77.0%

STOK-803.4%

Net Margin (TTM)

SNDX-87.5%

STOK-753.6%

FCF Margin (TTM)

SNDX-87.6%

STOK-654.9%

Net Income (TTM)

SNDX$-221M

STOK$-208M

FCF (TTM)

SNDX$-221M

STOK$-181M

EPS (TTM)

SNDX-$2.48

STOK-$3.15

ROE (TTM)

SNDX-37294.0%

STOK-5936.0%

ROA (TTM)

SNDX-3911.0%

STOK-5146.0%

ROIC (TTM)

SNDX-4756.0%

STOK-5936.0%

Cash

SNDX$336M

STOK$110M

Debt

SNDX$588M

STOK$0

Net Cash/Debt

SNDX$-252M

STOK$110M

Current Ratio (TTM)

SNDX6.77x

STOK7.69x

Quick Ratio (TTM)

SNDX6.32x

STOK7.34x

Debt/Equity (TTM)

SNDX38.95x

STOK0.00x

Debt/Assets (TTM)

SNDX0.0%

STOK0.0%

Interest Coverage (TTM)

SNDXN/A

STOKN/A

Net Debt/EBITDA (TTM)

SNDX0.00x

STOK0.00x

Beta

SNDX0.40

STOK1.36

52W Performance

SNDX3.0%

STOK-18.9%

YTD Performance

SNDX-20.2%

STOK-19.9%

% from 52W High

SNDX-33.6%

STOK-38.5%

% from 52W Low

SNDX30.8%

STOK21.8%

Asset Turnover (TTM)

SNDX0.45x

STOK0.07x

FCF Yield (TTM)

SNDX-14.7%

STOK-11.7%

Earnings Yield (TTM)

SNDX-14.7%

STOK-13.5%

Dividend Yield (TTM)

SNDXN/A

STOKN/A

Rule of 40

SNDX135.1

STOK-741.1

EV/GP/RG

SNDX0.15

STOKN/A

Ticker research

View SNDX research View STOK research

Metric	SNDX Syndax Pharmaceuticals Inc	STOK Stoke Therapeutics Inc
Market & Valuation
Market Cap	$1.51B	$1.54B
Enterprise Value	$1.76B	$1.43B
Price	$16.99	$24.74
P/E Ratio	N/A	N/A
P/S Ratio	5.97x	55.85x
EV/Sales	6.97x	51.86x
EV/EBITDA	1,613.51x	53.69x
P/B Ratio	104.09x	4.78x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.96x	-7.92x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	47.27x
Revenue & Growth
Revenue (TTM)	$252M	$28M
Revenue Growth (YoY)	222.7%	-86.2%
Forward Rev Growth	41.0%	62.9%
Profitability
Gross Margin (TTM)	95.8%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-77.0%	-803.4%
Net Margin (TTM)	-87.5%	-753.6%
FCF Margin (TTM)	-87.6%	-654.9%
Net Income (TTM)	$-221M	$-208M
FCF (TTM)	$-221M	$-181M
EPS (TTM)	-$2.48	-$3.15
ROE (TTM)	-37294.0%	-5936.0%
ROA (TTM)	-3911.0%	-5146.0%
ROIC (TTM)	-4756.0%	-5936.0%
Financial Health
Cash	$336M	$110M
Debt	$588M	$0
Net Cash/Debt	$-252M	$110M
Current Ratio (TTM)	6.77x	7.69x
Quick Ratio (TTM)	6.32x	7.34x
Debt/Equity (TTM)	38.95x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.40	1.36
52W Performance	3.0%	-18.9%
YTD Performance	-20.2%	-19.9%
% from 52W High	-33.6%	-38.5%
% from 52W Low	30.8%	21.8%
Efficiency & Yields
Asset Turnover (TTM)	0.45x	0.07x
FCF Yield (TTM)	-14.7%	-11.7%
Earnings Yield (TTM)	-14.7%	-13.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	135.1	-741.1
EV/GP/RG	0.15	N/A
Ticker research	View SNDX research	View STOK research

Valuation

P/S Ratio

SNDX

5.97x

STOK

55.85x

EV/FCF

SNDX

-7.96x

STOK

-7.92x

Growth & revenue

Revenue Growth TTM

SNDX

222.7%

STOK

-86.2%

Forward Revenue Growth

STOK

62.9%

SNDX

41.0%

Profitability & performance

Gross Margin

SNDX

95.8%

STOK

0.0%

ROE

STOK

-5936.0%

SNDX

-37294.0%

FCF Yield %

STOK

-11.7%

SNDX

-14.7%

52-Week Performance

SNDX

3.0%

STOK

-18.9%

Detailed metrics comparison

SNDX

Syndax Pharmaceuticals Inc

STOK

Stoke Therapeutics Inc

Market Cap

SNDX$1.51B

STOK$1.54B

Enterprise Value

SNDX$1.76B

STOK$1.43B

Price

SNDX$16.99

STOK$24.74

P/E Ratio

SNDXN/A

STOKN/A

P/S Ratio

SNDX5.97x

STOK55.85x

EV/Sales

SNDX6.97x

STOK51.86x

EV/EBITDA

SNDX1,613.51x

STOK53.69x

P/B Ratio

SNDX104.09x

STOK4.78x

P/FCF Ratio

SNDXN/A

STOKN/A

EV/FCF

SNDX-7.96x

STOK-7.92x

PEG Ratio

SNDXN/A

STOKN/A

Forward P/E (NTM)

SNDXN/A

STOKN/A

Forward P/S (NTM)

SNDXN/A

STOK47.27x

Revenue (TTM)

SNDX$252M

STOK$28M

Revenue Growth (YoY)

SNDX222.7%

STOK-86.2%

Forward Rev Growth

SNDX41.0%

STOK62.9%

Gross Margin (TTM)

SNDX95.8%

STOK0.0%

Operating Margin (TTM)

SNDX0.0%

STOK0.0%

EBITDA Margin (TTM)

SNDX-77.0%

STOK-803.4%

Net Margin (TTM)

SNDX-87.5%

STOK-753.6%

FCF Margin (TTM)

SNDX-87.6%

STOK-654.9%

Net Income (TTM)

SNDX$-221M

STOK$-208M

FCF (TTM)

SNDX$-221M

STOK$-181M

EPS (TTM)

SNDX-$2.48

STOK-$3.15

ROE (TTM)

SNDX-37294.0%

STOK-5936.0%

ROA (TTM)

SNDX-3911.0%

STOK-5146.0%

ROIC (TTM)

SNDX-4756.0%

STOK-5936.0%

Cash

SNDX$336M

STOK$110M

Debt

SNDX$588M

STOK$0

Net Cash/Debt

SNDX$-252M

STOK$110M

Current Ratio (TTM)

SNDX6.77x

STOK7.69x

Quick Ratio (TTM)

SNDX6.32x

STOK7.34x

Debt/Equity (TTM)

SNDX38.95x

STOK0.00x

Debt/Assets (TTM)

SNDX0.0%

STOK0.0%

Interest Coverage (TTM)

SNDXN/A

STOKN/A

Net Debt/EBITDA (TTM)

SNDX0.00x

STOK0.00x

Beta

SNDX0.40

STOK1.36

52W Performance

SNDX3.0%

STOK-18.9%

YTD Performance

SNDX-20.2%

STOK-19.9%

% from 52W High

SNDX-33.6%

STOK-38.5%

% from 52W Low

SNDX30.8%

STOK21.8%

Asset Turnover (TTM)

SNDX0.45x

STOK0.07x

FCF Yield (TTM)

SNDX-14.7%

STOK-11.7%

Earnings Yield (TTM)

SNDX-14.7%

STOK-13.5%

Dividend Yield (TTM)

SNDXN/A

STOKN/A

Rule of 40

SNDX135.1

STOK-741.1

EV/GP/RG

SNDX0.15

STOKN/A

Ticker research

View SNDX research View STOK research

Metric	SNDX Syndax Pharmaceuticals Inc	STOK Stoke Therapeutics Inc
Market & Valuation
Market Cap	$1.51B	$1.54B
Enterprise Value	$1.76B	$1.43B
Price	$16.99	$24.74
P/E Ratio	N/A	N/A
P/S Ratio	5.97x	55.85x
EV/Sales	6.97x	51.86x
EV/EBITDA	1,613.51x	53.69x
P/B Ratio	104.09x	4.78x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.96x	-7.92x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	47.27x
Revenue & Growth
Revenue (TTM)	$252M	$28M
Revenue Growth (YoY)	222.7%	-86.2%
Forward Rev Growth	41.0%	62.9%
Profitability
Gross Margin (TTM)	95.8%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-77.0%	-803.4%
Net Margin (TTM)	-87.5%	-753.6%
FCF Margin (TTM)	-87.6%	-654.9%
Net Income (TTM)	$-221M	$-208M
FCF (TTM)	$-221M	$-181M
EPS (TTM)	-$2.48	-$3.15
ROE (TTM)	-37294.0%	-5936.0%
ROA (TTM)	-3911.0%	-5146.0%
ROIC (TTM)	-4756.0%	-5936.0%
Financial Health
Cash	$336M	$110M
Debt	$588M	$0
Net Cash/Debt	$-252M	$110M
Current Ratio (TTM)	6.77x	7.69x
Quick Ratio (TTM)	6.32x	7.34x
Debt/Equity (TTM)	38.95x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.40	1.36
52W Performance	3.0%	-18.9%
YTD Performance	-20.2%	-19.9%
% from 52W High	-33.6%	-38.5%
% from 52W Low	30.8%	21.8%
Efficiency & Yields
Asset Turnover (TTM)	0.45x	0.07x
FCF Yield (TTM)	-14.7%	-11.7%
Earnings Yield (TTM)	-14.7%	-13.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	135.1	-741.1
EV/GP/RG	0.15	N/A
Ticker research	View SNDX research	View STOK research